Dissertation Defense

FGFR4 overexpression and hotspot mutations are druggable targets for endocrine-resistant lobular breast cancer



Date
December 3, 2018
Time
2:00 PM
Speaker(s)
Kevin Max Levine
Graduate student in Cellular and Molecular Pathology
Location
Eye and Ear Institute, 5th Floor, Boardroom 520
Contact
Lauren Zielinski




lez26@pitt.edu